Phase 2 Lymphangioleiomyomatosis Clinical Trials
2 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Lymphangioleiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)100 enrolled1 locationNCT01799538
Recruiting
Phase 2
Doxycycline in Lymphanioleiomyomatosis (LAM): a randomised double blind placebo controlled crossover trial
Lymphangioleiomyomatosis
Dr.Deborah Yates30 enrolled1 locationACTRN12608000325303